{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P00533",
      "entity_text" : "EGFR",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P16070",
      "entity_text" : "CD44",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_0031" ],
      "TissueType" : [ "tissuelist:TS-0591" ],
      "Cellular_component" : [ "go:GO:0009986" ]
    }
  },
  "verbose_text" : "Conversely, treatment with 4-methylumbelliferone (4-MU; an inhibitor of HAS) prior to stimulation with TGF-beta1, inhibited the expression of CD44 and EGFR, abolished the interaction between CD44 and EGFR.",
  "reading_complete" : "2020-08-03T16:44:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:42:46Z",
  "trigger" : "interaction",
  "evidence" : [ "interaction between CD44 and EGFR" ],
  "pmc_id" : "4494581",
  "score" : 0
}